Metabolomics and biochemical profiling in drug discovery and development

Steven M. Watkins, J. Bruce German

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Metabolomics brings a different and complementary perspective to biomedical research and therapeutic development. Metabolites are measurable, directly responsible for health, and changeable through intervention. By definition, the concentrations of metabolites are the direct reflection of metabolism, and by measuring changes in metabolite concentrations, the full range of biochemical effects induced by a therapeutic intervention can be determined. In a clinical setting, metabolomics can be used to diagnose or predict disease, stratify patient populations by their specific metabolism, or to determine the safety or efficacy of a therapeutic intervention. Metabolomics is useful in virtually all aspects of biomedical research, and it is likely to evolve into an essential component of the drug discovery and development process.

Original languageEnglish (US)
Pages (from-to)224-228
Number of pages5
JournalCurrent Opinion in Molecular Therapeutics
Volume4
Issue number3
StatePublished - Jun 2002
Externally publishedYes

Fingerprint

Metabolomics
Drug Discovery
Biomedical Research
Essential Drugs
Therapeutics
Safety
Health
Research
Population

Keywords

  • Drug development
  • Metabolites
  • Metabolomics
  • Personalized medicine
  • Profiling

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Metabolomics and biochemical profiling in drug discovery and development. / Watkins, Steven M.; German, J. Bruce.

In: Current Opinion in Molecular Therapeutics, Vol. 4, No. 3, 06.2002, p. 224-228.

Research output: Contribution to journalArticle

Watkins, Steven M. ; German, J. Bruce. / Metabolomics and biochemical profiling in drug discovery and development. In: Current Opinion in Molecular Therapeutics. 2002 ; Vol. 4, No. 3. pp. 224-228.
@article{5811622c8b2b4f59bc0af00352ec1053,
title = "Metabolomics and biochemical profiling in drug discovery and development",
abstract = "Metabolomics brings a different and complementary perspective to biomedical research and therapeutic development. Metabolites are measurable, directly responsible for health, and changeable through intervention. By definition, the concentrations of metabolites are the direct reflection of metabolism, and by measuring changes in metabolite concentrations, the full range of biochemical effects induced by a therapeutic intervention can be determined. In a clinical setting, metabolomics can be used to diagnose or predict disease, stratify patient populations by their specific metabolism, or to determine the safety or efficacy of a therapeutic intervention. Metabolomics is useful in virtually all aspects of biomedical research, and it is likely to evolve into an essential component of the drug discovery and development process.",
keywords = "Drug development, Metabolites, Metabolomics, Personalized medicine, Profiling",
author = "Watkins, {Steven M.} and German, {J. Bruce}",
year = "2002",
month = "6",
language = "English (US)",
volume = "4",
pages = "224--228",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "3",

}

TY - JOUR

T1 - Metabolomics and biochemical profiling in drug discovery and development

AU - Watkins, Steven M.

AU - German, J. Bruce

PY - 2002/6

Y1 - 2002/6

N2 - Metabolomics brings a different and complementary perspective to biomedical research and therapeutic development. Metabolites are measurable, directly responsible for health, and changeable through intervention. By definition, the concentrations of metabolites are the direct reflection of metabolism, and by measuring changes in metabolite concentrations, the full range of biochemical effects induced by a therapeutic intervention can be determined. In a clinical setting, metabolomics can be used to diagnose or predict disease, stratify patient populations by their specific metabolism, or to determine the safety or efficacy of a therapeutic intervention. Metabolomics is useful in virtually all aspects of biomedical research, and it is likely to evolve into an essential component of the drug discovery and development process.

AB - Metabolomics brings a different and complementary perspective to biomedical research and therapeutic development. Metabolites are measurable, directly responsible for health, and changeable through intervention. By definition, the concentrations of metabolites are the direct reflection of metabolism, and by measuring changes in metabolite concentrations, the full range of biochemical effects induced by a therapeutic intervention can be determined. In a clinical setting, metabolomics can be used to diagnose or predict disease, stratify patient populations by their specific metabolism, or to determine the safety or efficacy of a therapeutic intervention. Metabolomics is useful in virtually all aspects of biomedical research, and it is likely to evolve into an essential component of the drug discovery and development process.

KW - Drug development

KW - Metabolites

KW - Metabolomics

KW - Personalized medicine

KW - Profiling

UR - http://www.scopus.com/inward/record.url?scp=0036624293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036624293&partnerID=8YFLogxK

M3 - Article

C2 - 12139307

AN - SCOPUS:0036624293

VL - 4

SP - 224

EP - 228

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 3

ER -